Investment Summary |
|
|---|---|
| Date | 2025-09-22 |
| Target | Decision Focus |
| Sector | Internet Software and Services |
| Investor(s) | Keensight Capital |
| Sellers(s) | VIA equity |
| Deal Type | Secondary Buyout |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 5.5B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €600 million and will consider business with up to €400 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 52 of 53 |
| Sector: Internet Software and Services M&A | 6 of 6 |
| Type: Secondary Buyout M&A Deals | 13 of 13 |
| Country: Denmark M&A | 1 of 1 |
| Year: 2025 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-09-17 |
Isto Biologics
Hopkinton, Massachusetts, United States Isto Biologics is an orthobiologics company providing advanced solutions for the spine and orthopedics markets. Isto Biologics offers an innovative portfolio of products, including InQu Bone Graft Extender & Substitute, Influx Trabecular Bone Graft, and CellPoint Concentrated Bone Marrow Aspirate System. Isto Biologics was founded in 2016 and is based in Hopkinton, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-10-13 |
Bedfont Scientific
Kent, United Kingdom Bedfont Scientific is a manufacturer of exhaled breath and gas monitoring instruments. Bedfont Scientific is based in Kent, United Kingdom. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| PE ASSETS | 500M EUR |
| Size | Middle-Market |
| Type | Sector Focused |
VIA equity a/s is a private equity firm focused on buyouts and growth capital investments in Northern European companies. VIA can commit up to €35 million per investment and seeks companies generating revenues of €10 to €100 million. VIA will consider investing across a range of sectors, however, the Firm prefers opportunities in the technology, media, and telecom industries. VIA equity was formed in 2006 and is based in Hellerup, Denmark.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 30 |
| Sector: Internet Software and Services M&A | 3 of 3 |
| Type: Secondary Buyout M&A Deals | 10 of 10 |
| Country: Denmark M&A | 19 of 19 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-25 |
DMRZ
Dusseldorf, Germany DMRZ provides a cloud-based do-it-yourself billing software solution to other healthcare providers and supports its customers in the reimbursement of prescriptions with the SHIs in Germany. DMRZ was founded in 2007 and is based in Dusseldorf, Germany. |
Buy | - |
